We and others have previously proposed that albumin is an inverse surrogate marker of disease activity in SLE, in particular in patients with renal disease, who lose albumin in the urine.28 48 An increased cumulative inflammatory burden, as indicated by lower albumin levels in MI-SLE, may increase the risk of MI through several mechanisms. This evidence concerns the gene ALB and kidney disorder.